TL;DR
This paper introduces a novel rat model for spinal sacral nerve injury (SSNI) by surgically crushing the bilateral spinal sacral nerves. This model effectively replicates the detrusor underactivity and bladder dysfunction seen in human patients, providing a crucial tool for understanding the pathological processes and evaluating potential therapeutic strategies for this often-overlooked condition.
What Problem Does This Paper Address?
Spinal sacral nerve injury (SSNI) is a serious condition that can result from various causes like sacral fractures, tethered cord syndrome, and sacral tumors. A key consequence of SSNI is bladder denervation, leading to detrusor underactivity (DU) and subsequent urinary tract dysfunctions. Despite its prevalence and impact on quality of life, there's a significant lack of clinical experience and effective treatment options for SSNI-induced DU. Furthermore, existing animal models for DU often involve spinal cord injuries that also cause lower limb paralysis, making them less suitable for studying SSNI specifically, which typically affects bladder function without significant motor deficits. This paper aims to address this gap by developing and characterizing a reliable and reproducible rat model that mimics the functional, morphological, and molecular aspects of human SSNI-induced DU.
Methods
The researchers established a novel SSNI rat model by surgically crushing the bilateral spinal sacral nerves at the root near the foramen, mimicking clinical scenarios. They used 40 adult female Sprague-Dawley rats, divided into a sham group (n=20) and a crush group (n=20).
Key evaluation methods included:
- Urodynamic Testing: To assess bladder function, including leakage point pressure (LPP), maximum bladder volume (MBV), and bladder compliance.
- Ultrasonography and Retrograde Urography: Imaging techniques to evaluate bladder morphology and volume.
- Histological Examination: Hematoxylin-eosin (H&E) and Masson's trichrome staining were used to examine the microstructure of nerves and bladders, assessing tissue architecture, inflammation, and collagen deposition.
- Immunofluorescence Staining: To detect Schwann cells, axons (NF-200), and collagen (Col-1, Col-3) in nerves and bladders, respectively, to evaluate nerve degeneration and fibrosis.
- Polymerase Chain Reaction (PCR): To analyze the expression of pro-inflammatory factors (IL-1b, IL-6, TNF-a) in nerves and pro-fibrosis factors (TGF, collagen, CTGF) in bladders.
- CatWalk Gait Analysis: To assess lower limb motor function and determine if the SSNI model induced paralysis, which would differentiate it from other DU models.
Datasets
Not discussed in the paper. The study utilized experimental data generated from the animal model.
Key Insights and Ideas
- A Clinically Relevant Model: The developed SSNI model successfully replicates detrusor underactivity and bladder dysfunction without causing significant lower limb paralysis, making it a more accurate representation of human SSNI than existing models.
- Early Inflammation and Later Fibrosis: The study highlights a biphasic pathological process: initial acute inflammation in nerves and bladders at 1 week post-injury, followed by bladder fibrosis, which is a key contributor to long-term dysfunction.
- Nerve Degeneration and Collagen Remodeling: Histological and immunofluorescence findings clearly demonstrated axonal degeneration, Schwann cell death, and significant collagen remodeling in the bladder wall of the crush group, underscoring the structural damage caused by SSNI.
- Functional Deficits Mirror Pathological Changes: The observed functional impairments in bladder voiding (e.g., increased LPP, MBV, and compliance) directly correlated with the structural and molecular changes in the nerves and bladder.
Key Results
- Functional Bladder Dysfunction: Rats in the crush group exhibited significantly higher leakage point pressure and maximum bladder volume, along with increased bladder compliance, at 1 and 4 weeks post-injury compared to the sham group.
- Morphological Changes: Ultrasonography and retrograde urography revealed significantly larger bladder volumes in the crush group. Histological analysis showed bladder wall thickening, atrophy of the detrusor muscle, vasodilation, and inflammatory infiltration in the crush group.
- Nerve Damage: Immunofluorescence staining confirmed a significantly lower density of NF-200 positive nerve fibers and S100-positive Schwann cells in the spinal sacral nerves of the crush group, indicating degeneration and demyelination.
- Inflammation and Fibrosis Dynamics: PCR analysis revealed elevated pro-inflammatory factors in nerves and pro-fibrosis factors in the bladder at 1 week post-injury, which returned to normal levels by 4 weeks, suggesting a temporal pattern of injury response.
- No Motor Deficits: CatWalk gait analysis showed no significant differences in lower limb motor function between the sham and crush groups, confirming the model's specificity for bladder dysfunction.
Limitations and Future Work
The authors acknowledge that while their model demonstrates increased bladder compliance at 4 weeks, they speculate that this might decrease with further fibrosis development if the observation period were extended. They suggest that this diphasic action (denervation followed by fibrosis) is a dynamic process.
Future work could focus on:
- Therapeutic Strategy Evaluation: The established model is presented as a valuable tool for evaluating the efficacy of new therapeutic strategies for SSNI-associated detrusor underactivity.
- Understanding Recovery Mechanisms: Further research can explore how nerve regeneration and bladder fibrosis change over time and how these processes can be modulated to facilitate recovery.
- Long-term Effects: Investigating the long-term consequences of SSNI and the potential for complete recovery or chronic dysfunction would be beneficial.
Summary updated